Shield Therapeutics Plc (LSE) · Health Technology. hisse senedi canlı fiyat verisi ve teknik analiz görünümü. LSE (Londra Borsası) verilerini Alerta Chart üzerinden takip edin.
Veri erişimi kontrol ediliyor...
Shield Therapeutics Plc is a commercial stage specialty pharmaceutical company, which engages in addressing iron deficiency with its lead product Accrufer. It operates the Feraccru and PT20 segments. The Feraccru segment refers to the development and commercialization of this product. The PT20 segment related to the development of its secondary asset. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Gateshead Quays, the United Kingdom.
Alerta Chart Pro Terminal ile aynı anda 4 grafiği takip edebilir, derinlik (order book) verilerini görebilir ve 25 aktif alarm kurabilirsiniz.
Ücretsiz Başla